TradingView
lauralea
Jul 22, 2020 1:12 AM

Gap is my Middle name 

Emergent Biosolutions, Inc.NYSE

Description

This stock goes up, then gaps down, goes up, gaps down. Would not be fun to own a whole lot of it!
Is a virus stock so I am sure gaps are probably based on news
No pattern in particular..just a gap stock/volatile as a vocano.. providing support and resistance
Earnings 7-30 amc and they do miss at times/short is not as high right now as I would think/perhaps it will rise with the stock cos chances are..it will gap down again!

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin; and Trobigard a combination drug-device auto injector product candidate. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; CHIKUNGUNYA, a chikungunya virus-like particle vaccine; and ADENOVIRUS 4/7. Further, the company offers other discovery and preclinical product candidates addressing PHTs, including viral hemorrhagic fevers caused by Ebola, Marburg, Sudan, and Lassa viruses; diarrheal disease caused by Shigella; and heat-labile toxin producing enterotoxigenic Escherichia coli, etc. Additionally, it offers FLU-IGIV to treat Influenza A infection; and ZIKV-IG, a prophylaxis for Zika infections, as well as contract development and manufacturing services to pharma and biotech industries, and government agencies/non-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Comments
UnknownUnicorn7172660
THIS STOCK IS DRIVING ME CRAZY! THANKS FOR YOUR RESEARCH!
lauralea
@tereneuwald1, I like this stock. But unless it hits a clear bottom, i plan to stay away. I think mad money guy, the democrap, likes this one
UnknownUnicorn7172660
@lauralea, Thanks Laura, I like this stock too, I think its a good bet in the long run. what do you think would be a nice point of entry? I see a gap again at around 100. do you think that would be it?
lauralea
@tereneuwald1, 106.87...lol if it goes under that then the gap up would be my bet btw 98 and 102ish. It is possible that many stocks in this sector are rotating out i think for a breather. I set alerts for myself and they are texted to my phone from TD Ameritrade. I have one set for 107. If I look and it looks to be going past the level of support there formed from the top of a red candle and almost to gap, I reset it again...if it doesnt get support there..i would set an alert for 103..to be sure I catch the move. It is not unusual for me to change an alert 3 times to let a stock go down to where i feel it is safe. Thx (o:
UnknownUnicorn7172660
@lauralea, Thanks for your input! will do the same :)
lauralea
@tereneuwald1, It hit 108.11 today..buying kicked in. I am still waiting to make sure. I guess it depends on how bad you want the stock Good luck!
lauralea
@tereneuwald1, I think maybe it is trying to settle down/trying to get through R at prior gap down/Looks like it will not go much under 96ish
lauralea
@lauralea, But it did..)o:
More